Showing results (1831-1840 of 2,171) with videos related to
Sort By:
Pageof 218
The Journal of Investigative Dermatology|June 26, 2026
Impact of Online vs In-Person Management of Atopic Dermatitis on Quality of Life and Access to Care: A Randomized Controlled TrialApril W Armstrong, Alyssa M Roberts, Gina Kostandy, et al.American Journal of Clinical Dermatology|November 15, 2024
Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III StudiesEric L Simpson, Matthias Augustin, Diamant Thaçi, et al.Journal of Cardiac Failure|March 18, 2022
Medical Therapy During Hospitalization for Heart Failure With Reduced Ejection Fraction: The VICTORIA RegistryStephen J Greene, Justin A Ezekowitz, Kevin J Anstrom, et al.European Heart Journal|April 1, 2005
Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trialBrahmajee K Nallamothu, Eric R Bates, Judith S Hochman, et al.American Heart Journal|July 24, 2007
Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trialsCheuk-Kit Wong, L Kristin Newby, Manju V Bhapker, et al.American Heart Journal|September 11, 2013
Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non-ST-segment elevation acute coronary syndromes patients: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome trialAkshay Bagai, Jennifer A White, Yuliya Lokhnygina, et al.JACC. Advances|March 30, 2026
Worsening Kidney Function and Cardiovascular Outcomes in Type 2 Diabetes and Atherosclerotic DiseaseAbhinav Sharma, Amir Razaghizad, Susanna R Stevens, et al.ESC Heart Failure|October 22, 2024
Projecting the benefit of vericiguat in PARADIGM-HF and DAPA-HF populations: Insights from the VICTORIA trialVeraprapas Kittipibul, Robert J Mentz, Rebecca Young, et al.The American Journal of Cardiology|March 11, 2014
Angiographic outcomes with early eptifibatide therapy in non-ST-segment elevation acute coronary syndrome (from the EARLY ACS Trial)Vijay Kunadian, Robert P Giugliano, L Kristin Newby, et al.JAMA Dermatology|June 24, 2026
Online vs In-Person Care for Atopic Dermatitis: A Randomized Clinical TrialApril W Armstrong, Alyssa M Roberts, Gina Kostandy, et al.Pageof 218